Home › Pharma › Biotech › Page 7

Biotech

September 27, 2018 3839 Views

The U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on Epizyme’s tazemetostat trials, a ...

September 19, 2018 12696 Views

The Food and Drug Administration (FDA) just approved a new covered coronary stent device meant to treat perforations ...

September 17, 2018 4218 Views

Biotech company, Vital Therapies’ stock plunged by almost 89 percent after a Phase III trial of its cell ...

September 17, 2018 8734 Views

Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human ...

September 13, 2018 4024 Views

OncoResponse, a biotech startup formed with the University of Texas M.D. Anderson Cancer Center in Houston, announced, September ...

September 13, 2018 1163 Views

Gene therapy firm, 4D Molecular Therapeutics (4DMT) is on the verge of taking its therapies for adeno-associated viruses ...

September 12, 2018 3711 Views

Genome editing company, Inscripta has announced the acquisition of life sciences firm, Solana Biosciences, in a move meant ...

September 10, 2018 3510 Views

Patients suffering from Duchenne muscular dystrophy (DMD) and their families received disappointing news recently, when Pfizer Inc. announced ...

September 1, 2018 6715 Views

On August 30th Arvinas, a preclinical biotech that is developing protein therapies for metastatic cancers, filed with the ...